Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT06213415

Role of Oral Steroid Alone Versus Oral Steroid Plus Intratympanic Steroid Injection in Bell's Palsy

intratympanic steroid injection bell's palsy

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

About this study

Role of oral steroid alone versus oral steroid plus intratympanic steroid injection in Bell's palsy

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Mean Aged 18 years or more.
  • Acute unilateral facial palsy without skin lesions which developed within a 72-hour period and is present for 21 days or less.
  • Moderate to severe facial palsy [House-Brackmann grade IV or greater]

Exclusion criteria

  • Another cause of facial nerve paralysis that is not idiopathic.
  • Otologic disease including otitis media, temporal bone fracture, a previous history of facial nerve palsy in either side, history of otologic surgery, and suspected Ramsay Hunt syndrome.
  • Systemic disease including history of tuberculosis, history of head and neck cancer, other neurological disorders, recent use of ototoxic medications, liver or renal dysfunction, and other illnesses that would contraindicate the use of high-dose steroid therapy.
  • Pregnancy

Treatment and study plan

Corticosteroid

Drug

Oral steroids plus intratympanic injection

Primary outcomes

  1. Success or failure of procedure to treat Bell's palsy

    Time frame: 6 months

    Degree of regaining function to facial nerve Unit of measurement : nerve conduction study

    Measurement tool :endoscopic injection by ear microscope

Study contacts

Contact information is provided by the study sponsor or research team.

Ahmed Mohamed Alaa

CONTACT

[email protected]

01007575074

Hussein Farid mostafa wishahi

CONTACT

[email protected]

01001775898

Sponsors and collaborators

Lead sponsor

Assiut University

Other

Registry information

Important dates

Study start
2024
Primary completion
2025
Study completion
2026
First posted
Jan 19, 2024
Registry last updated
Jan 19, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.